| Code | CSB-AP000811HU |
| Abbreviation | Recombinant Human CCL1 protein, partial (Active) |
| MSDS | |
| Size | $354 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
CCL1 (also known as I-309) plays a critical role in recruiting CCR8-expressing T cells and monocytes to sites of inflammation, making it a key target in studies of Th2-mediated immunity and tumor immune evasion. This tag-free recombinant human CCL1 encompasses the mature protein sequence (residues 23–96) and demonstrates confirmed chemotactic activity on primary human T-lymphocytes at 10–100 ng/ml, providing a suitable basis for Transwell migration assays, CCR8 signaling pathway analyses involving MAPK and NF-κB activation, and in vivo models of inflammatory cell trafficking. Endotoxin levels below 1.0 EU/μg minimize LPS-driven artifacts that can confound immune cell functional readouts, while purity exceeding 97% by SDS-PAGE supports use as a reliable reference standard in CCL1 detection assays or as a coating antigen for anti-CCL1 antibody validation by ELISA. The E. coli-derived, non-glycosylated format ensures batch-to-batch consistency for reproducible dose-response experiments.
There are currently no reviews for this product.